2-Methyl-1H-indole-5-carboxylic acid

Catalog No.: 
ACGNIS092
CAS No.: 
496946-80-6
Molecular Formula: 
C10H9NO2
Molecular Weight: 
175.19
2-Methyl-1H-indole-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$57.00In stockIn stock
250mg96%$85.00In stockIn stock
1g96%$304.00In stockIn stock
5g96%$1192.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-1H-indole-5-carboxylic acid
IUPAC Name2-methyl-1H-indole-5-carboxylic acid
MDL No.MFCD07440342
Molecular FormulaC10H9NO2
Molecular Weight175.19
SMILESO=C(C1=CC2=C(NC(C)=C2)C=C1)O
InChI KeySTRAEOQKYFMDMG-UHFFFAOYSA-N
SynonymEN300-87386 | SY104782 | DTXSID30616395 | SB14913 | WUA94680 | AKOS000346209 | DS-9193 | methyl 5-carboxy indole | AMY9412 | I10098 | SCHEMBL1105989 | 2-methyl-1H-indole-5-carboxylicacid | 2-methyl-1H-indole-5-carboxylic acid | MFCD07440342 | STRAEOQKYFMD
CAS No.496946-80-6
PubChem CID21622232

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGNIS092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSTPV857 route compound structure diagram
    ACSTPV85757663-18-0In Stock
  2. Then
  3. ACGNIS092 route product structure diagram
    ACGNIS092496946-80-6In Stock
Inquiry

2. ACGNIS092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCFRD751 route compound structure diagram
    ACCFRD75153600-12-7In Stock
  2. Then
  3. ACGNIS092 route product structure diagram
    ACGNIS092496946-80-6In Stock
Inquiry

3. ACGNIS092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGNIS092 route product structure diagram
    ACGNIS092496946-80-6In Stock
Inquiry

Comments (0)